Alpha DNA Investment Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,255	Closed	-$796K	–	175
2024 Q4	$796K	Buy	2,255 +163	+8%	+$57.5K	0.3%	67
2024 Q3	$750K	Sell	2,092 -940	-31%	-$337K	0.28%	83
2024 Q2	$966K	Buy	+3,032	New	+$966K	0.38%	53